Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study
Telitacicept monotherapy is safe and effective, and combination with corticosteroids and immunosuppressants may improve the remission rate in patients with better baseline renal function, but modestly increases the risk of adverse reactions.
Authors
- G.Y. Liu
- Huixia Cao (ORCID: https://orcid.org/0000-0002-4729-2210)
- Xuegang Niu
- Fengmin Shao (ORCID: https://orcid.org/0000-0002-7534-1585)
- Xiaojing Jiao
- Xiaoling Zhang (ORCID: https://orcid.org/0000-0003-1157-0976)
- Tao Lin (ORCID: https://orcid.org/0009-0006-0791-9310)
Institutions
- Henan Provincial People's Hospital (CN)
- Zhengzhou People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.3389/fphar.2025.1642137
- Citations
- 4
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 5.72